OMEGA HEALTHCARE FILES 8-K ON FINANCIAL RESULTS

TL;DR

**Omega Healthcare just dropped an 8-K with fresh financial results, so check their numbers.**

AI Summary

OMEGA HEALTHCARE INVESTORS, INC. filed an 8-K on February 7, 2024, to report on its 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits.' This filing indicates that the company is providing updated financial information, likely related to its recent performance. For investors, this matters because it offers a timely look into the company's financial health, which can influence stock price and future dividend payouts, especially for a Real Estate Investment Trust (REIT) like Omega Healthcare.

Why It Matters

This filing provides investors with crucial, up-to-date financial performance data, enabling them to assess the company's current health and make informed investment decisions.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any immediate new risks or significant changes.

Analyst Insight

A smart investor would review the detailed financial statements and results of operations that will be included as exhibits to this 8-K to understand the company's current financial performance and its implications for future dividends and stock value.

Key Players & Entities

• OMEGA HEALTHCARE INVESTORS, INC. (company) — the registrant filing the 8-K
• February 7, 2024 (date) — date of earliest event reported and filing date
• 303 International Circle, Suite 200 Hunt Valley, Maryland 21030 (address) — principal executive offices of the registrant
• 410-427-1700 (phone_number) — registrant's telephone number
• Maryland (state) — state of incorporation for Omega Healthcare Investors, Inc.

FAQ

From the Filing

0000888491-24-000004.txt : 20240207 0000888491-24-000004.hdr.sgml : 20240207 20240207163630 ACCESSION NUMBER: 0000888491-24-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240207 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 24604814 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 ohi-20240207x8k.htm 8-K 0000888491 false 0000888491 2024-02-07 2024-02-07 ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ​ ​ ​ ​ ​ ​ FORM 8-K ​ ​ ​ ​ ​ ​ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): February 7, 2024 ​ OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) ​ Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) ​ 303 International Circle, Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code) ​ ( 410 ) 427-1700 (Registrant’s telephone number, including area code) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act. ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 : ​ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock , $.10 par value OHI New York Stock Exchange ​ Item 2.02     Regulation FD Disclosure ​ On February 7, 2024, Omega Healthcare Investors, Inc. (“Omega”) issued a press release regarding its financial results for the quarter ended December 31, 2023. Omega’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. ​ The information in this Item 2.02 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or oth